Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?

NCT00749619 is registered in ClinicalTrials.gov with Western Galilee Hospital-Nahariya as lead sponsor.

NCT NCT00749619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00749619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Heparin to Taurolock-TM CLS in HD Patients With TCC Dose it Improve Catheter Patency Problems ?
Lead sponsor
Western Galilee Hospital-Nahariya
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2007
Completion date
August 31, 2008
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, hemodialysis